scholarly journals A study on distribution pattern of lower respiratory tract infections in children under 5 years in a tertiary care centre

2018 ◽  
Vol 5 (2) ◽  
pp. 456
Author(s):  
Srinivasa S. ◽  
Shruthi Patel

Background: Respiratory infections are the leading cause of mortality in children below 5 years in India as well as worldwide. 16% mortality in children below 5 years is attributed to lower respiratory tract infection. Various factors influence the occurrence of the disease like environmental factors, lack of immunization, malnutrition. Present study was conducted to know the distribution pattern of lower respiratory tract infections, common pathogens associated with respiratory infections and risk factors associated with it. Methods: This study was conducted in Department of Pediatrics, KIMS Bangalore for a period of 1 year from January 2016 to December 2016. Total of 172 children admitted to ward and ICU with history suggestive of respiratory infection were included in the study after excluding congenital heart problems, congenital lung problems and immunodeficiency state.Results: In the present study, male predominance (59.3%) was observed. The incidence of respiratory tract infection was 17.5%. The common pathogen isolated was streptococcus pneumoniae. Most common respiratory infections included bronchopneumonia followed by bronchiolitis, croup, and lobar pneumonia. The common symptoms were cough, fever and hurried breathing. Anemia was observed in majority of them. Conclusion: Respiratory infections if timely managed, the mortality associated with it can be reduced. Pneumonia is a major killer disease in children below 5 years in India. Understanding the symptoms and signs and time of referral to tertiary centre not only reduces the mortality but it also reduces morbidity. So, it is important to create awareness among the health care personnel regarding common age of presentation of various types of respiratory infection and warning sign. 

2018 ◽  
Vol 1 (1) ◽  
pp. 5-8
Author(s):  
Henish Shakya ◽  
Saurav Singh ◽  
Ashish Lakhey

Introduction: Lower respiratory tract infection is a major cause of death in children in a developing country and anemia is found to be one of the commonest associated cofactors. This study was aimed to determine association of anemia in children with lower respiratory tract infections.Materials and Methods: The retrospective study was done over a one-year period for children under 5 years of age, admitted in Pediatric Ward of a tertiary Hospital in Lalitpur. The study included 100 diagnosed cases of lower respiratory tract infections as per WHO criteria and 100 age and sex matched patients who did not have respiratory complaints as controls, excluding prematurity, chronic diseases, malnutrition and severe systemic illness. Appropriate clinical history, examination routine investigations like hemoglobin, peripheral smear, and Chest X-ray were included.Results: The age distribution maximum children were in the age group of 3 months to 23 months with significant association with prevalence of both pneumonia (p value 0.005) and anemia (p value 0.002). Anemia was found to be a significant risk factor for LRTI (p value < 0.001) with odds ratio of 2.68 and 95% CI (1.51 – 4.75).Conclusions: Anemia was significantly found to be associated with lower respiratory tract infections and these children were found to be 2.68 times more susceptible to lower respiratory tract infections. Early diagnosis and prevention of anemia is thus important to reduce the incidence of lower respiratory tract infections in children.Nepalese Medical Journal. vol.1, No. 1, 2018, page: 5-8


PEDIATRICS ◽  
1966 ◽  
Vol 38 (1) ◽  
pp. 157-158
Author(s):  
HEINZ F. EICHENWALD

When the reviewer began to peruse this volume, he was unable to put it down until he had completed reading it. The book is full of fascinating items of information, a few of which might be cited: "the common cold and minor respiratory illnesses are most likely caused by the group of bacteria found in upper and lower respiratory tract infections (usually the pneumonococcus, and streptococcus);" "(the etiology of primary atypical pneumonia) is obscure but it is believed that a specific respiratory virus will eventually be recovered;" "meningitis . . . is so serious a disease that one must recommend that most upper and lower respiratory infections be treated with sulfonamide and/or antibiotics;" "(sepsis neonatorum should be treated) with sulfadiazine or some other intravenous sulfonamide."


2020 ◽  
Vol 7 (9) ◽  
pp. 1876
Author(s):  
Bhagat Ram Thakur ◽  
Pancham Kumar

Background: Frequency of nutritional rickets, its clinicobiochemical profile and its relationship to the lower respiratory tract infections in indoor patients from 2 to 60 months of age.Methods: Children aged 2 to 60 months admitted for the first time were included in the study and divided into two groups i.e. with and without clinical signs of rickets. Disease profile was studied in both groups. Incidence of lower respiratory tract infection was compared between two groups.  Children with clinicoradiological signs of rickets were also investigated for biochemical abnormalities.Results: During the one year study period a total of 393 children were admitted, 65 were found to have rickets constituted as study group and 328 were without rickets were included the controls. Rickets incidence was 16.5% of which majority (74.6%) were males and most rachitic children (64.6%) were below six months of age. Acute lower respiratory tract infection (64.6%) was commonest in study group and acute gastroenteritis (24.4%) in the controls. The rate of ALRTI was nearly three times in study group.  Frontal bossing (67.7%) was most common sign of rickets and increased alkaline phosphatase (93.8%) was the commonest biochemical abnormality.Conclusions: Nutritional rickets, a multifactorial disease, is easily preventable. The present study has revealed the high incidence of rickets i. e., 16.5% and also show the strong statistically significant association of nutritional rickets with acute lower respiratory tract infections.


2020 ◽  
Vol 16 (4) ◽  
pp. 382-388
Author(s):  
Aneta Rzepka ◽  
◽  
Anna Mania ◽  

Aim: The aim of this study was to analyse the clinical picture of respiratory tract infections among adult patients visiting their general practitioners. Materials and methods: The analysis included 301 adult patients who reported to their general practitioners due to respiratory tract infection. W assessed clinical symptoms, age, final diagnosis, probable aetiology, additional tests, including Actim® Influenza A&B rapid test to confirm influenza infection, radiographic and laboratory findings, as well as comorbidities, treatment used, vaccinations against influenza, and smoking habits. Results: Upper respiratory tract infections accounted for the vast majority of cases (74%), and these primarily included viral infections (62%), some of which required a change of therapy (23%) due to suspected secondary bacterial infection; lower respiratory tract infections accounted for 26% of cases. The main symptoms reported by the patients included cough, pharyngeal pain, fever, rhinitis, general malaise, nasal obstruction, headache, muscle pain and dysphonia. Acute pharyngitis was the dominant diagnosis (27%), followed by acute upper respiratory tract infection of multiple sites (13.6%), acute nasopharyngitis (known as common cold) (10%), purulent tonsillitis (11.6%), acute bronchitis (11%) and influenza (11%). Antibiotic therapy was used in 60% of patients with upper respiratory tract infection and 68% of patients with lower respiratory tract infection. Conclusions: The majority of patients were diagnosed with viral infections. The highest incidence of respiratory tract infections was observed in elderly individuals and patients with chronic cardiovascular diseases, lung diseases, diabetes mellitus and cancer. Smokers are more likely to develop lower respiratory tract infections (confirmed by additional tests) compared to other groups of patients. Individuals vaccinated against influenza account for a small proportion of patients.


2005 ◽  
Vol 10 (34) ◽  
Author(s):  
Collective Editorial team

A new parvovirus which causes lower respiratory tract infections in children has been identified for the first time, and has provisionally been called human bocavirus


2014 ◽  
Vol 3 (3) ◽  
Author(s):  
Inez Amelinda ◽  
Aziz Djamal ◽  
Elly Usman

AbstrakPenyakit infeksi saluran napas, terutama Infeksi Saluran Napas Bagian Bawah (ISPB) non tuberkulosis merupakan masalah kesehatan yang sering dihadapi. Penegakan diagnosis secara tepat dan tepat serta pemilihan antibiotika berdasarkan uji sensitivitas akan sangat membantu dalam tatalaksana penyakit. Kotrimoksazol merupakan antibiotika lini pertama dan banyak digunakan dibeberapa puskesmas sebagai salah satu pengobatan infeksi saluran napas bawah non tuberkulosis.Tujuannya untuk mengetahui bakteri penyebab infeksi saluran napas bawah serta sensitivitasnya terhadap kotrimoksazol. Penelitian ini merupakan studi deskriptif yang bersifat cross-sectional. Hasil penelitian menunjukkan bahwa terdapat 671 permintaan pemeriksaan mikrobiologis yang mencantumkan diagnosis klinis sebagai infeksi saluran napas bawah non tuberkulosis, sebagian besar ditegakkan diagnosis pneumonia (87,78%), diikuti oleh bronkiektasis (5,96%), bronkitis kronis (4,32%), dan bronkitis akut (1,94%). Selain itu, dari hasil penelitian ditemukan bakteri penyebab terbanyak infeksi saluran napas bawah non tuberkulosis yang utama adalah Klebsiella pneumoniae (51,92%), Streptococcus α hemolyticus (17,78%), dan Pseudomonas sp. (9,25%). Persentase sensitivitas bakteri penyebab infeksi saluran napas bawah terhadap kotrimoksazol sebesar 18,78%.Kata kunci: infeksi saluran napas bawah non tuberkulosis, bakteri penyebab, sensitivitas, kotrimoksazolAbstractRespiratory tract infections diseases, especially lower respiratory tract infections non tuberculosis is a health problem that is often encountered. Proper diagnosis and appropriate antibiotic selection based on testing and sensitivity will be helpful in the treatment of disease. Co-trimoxazole is a first-line antibiotic and widely used in several health centers as one of the treatment of lower respiratory tract infections non tuberculosis.The goal of this research was to discover which bacterium causes lower respiratory tract infection and its sensitivity to Cotrimoxazole. This research was a cross-sectional descriptive study. The results of research showed that there were 671 requests for microbiological examination which included a clinical diagnosis of lower respiratory tract infectionas non-tuberculosis, most revealed clinical sign as pneumonia (87,78%), followed by bronchiectasis (5,96%), chronicbronchitis (4,32%), and acutebronchitis (1,94%). Besides that, according to the research result, bacteria that cause lower respiratory tract infection are Klebsiella pneumoniae (51,92%), Streptococcus α hemolyticus (17,78%), and Pseudomonas sp. (9,25%). All the bacteria has 18,78% sensitivity to cotrimoxazole.Keywords:lower respiratory tract infection, bacteria, sensitivity, cotrimoxazole.


Author(s):  
Zeynep Onay ◽  
Deniz Mavi ◽  
Yetkin Ayhan ◽  
Sinem Can Oksay ◽  
Gulay Bas ◽  
...  

Background: COVID-19 outbreak lead to nationwide lockdown on the March 16th, 2020 in Turkey. We aimed to quantitively determine the change in frequency of upper and lower respiratory tract infections and asthma in pediatric population associated with COVID-19. Methods: The electronic medical record data of pediatric population admitted to the emergency department (ED), outpatient and inpatient clinics and pediatric intensive care unit (PICU) were analyzed with the diagnosis of Influenza, upper and lower respiratory tract infections (URTI, LRTI) acute bronchiolitis and asthma. The data of the first year of the pandemic was compared with the previous year. Results: In total 112496 admissions were made between April 1, 2019 and March 31, 2021 in our hospital. A decline was observed in ED admissions (-73%) and outpatient clinic (-70%) visits, hospitalizations (-41.5%) and PICU admissions (-42%). The admissions with the diagnosis of Influenza and URTI had a decline from 4.26% to 0.37% (p=0.0001), and from 81.54% to 75.62% (p=0.0001), respectively. An increase was observed in the LRTI, acute bronchiolitis and asthma (from 8.22% to 10.01% (p=0.0001), from 2.76% to 3.07% (p=0.027) and from 5.96% to 14% (p=0.0001), respectively). Conclusions: A dramatic decrease was observed in the number of admissions to ED and inpatient clinics and outpatient clinic visits and PICU admissions, and, when the rates of admissions were compared, the general rate of admissions to ED showed a decrease while inpatient, outpatient clinics and PICU admissions demonstrated an increase during the pandemic.


2020 ◽  
Vol 10 (5) ◽  
pp. 756-761
Author(s):  
Xiaofei Li ◽  
Lina Sheng ◽  
Juncai Tu ◽  
Lianqing Lou

This study evaluated the clinical efficacy and safety of piperacillin sulbactam in the treatment of lower respiratory tract infections, as well as the efficacy of silver nanoparticle-based disinfectant in equipment disinfection to reduce exogenous infection. From May 2018 to November 2018, 100 patients that had been diagnosed with a lower respiratory tract infection and hospitalized were divided into an experimental group and a control group. The experimental group was given piperacillin/sulbactam, and the control group was given mezlocillin/sulbactam, where 5.0 g was added to 100 mL of normal saline and administered via intravenous drip twice a day over a treatment course of 14 days. The cure rate of the experimental and control groups were 65.22% and 56.52% respectively. The efficacy rate was 91.30% and 91.30% respectively, with no significant difference between the two groups (P > 0.05). The results indicated that piperacillin/sulbactam is a safe, effective treatment for lower respiratory tract infections in elderly patients, the equipment was sterilized with silver nanoparticle-based disinfectant to reduce the incidence of adverse reactions and exogenous infections.


Author(s):  
Sagar A. Jawale

Introduction: In India and worldwide, there are millions of cases of acute respiratory infections annually killing hundreds of thousand people. It also has billions of dollars of losses worldwide. There are frequent outbreaks of deadly infections such as severe acute respiratory syndrome (SARS) in 2003, caused by a novel coronavirus (SARS-CoV), the novel swine-origin influenza A (H1N1) virus in Mexico in March 2009, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 and the current pandemic with Novel CoronaVirus -Covid19. I did my research to find a common effective, safe, and cheap therapynamed as Ozonated air inhalation therapy (OAIT) for respiratory infections. Materials and methods: In the last one year, I treated 21 patients (group A) with upper and lower respiratory tract infections (URTI and LRTI) with 0.1 ppm Ozonated air inhalation therapy (OAIT). OAIT was given as a monotherapy. In the same time period, 36 patients (group B) were given conventional treatment in the form of antibiotics, anti-histaminic and analgesics kept as control.


2018 ◽  
Author(s):  
Simon de Lusignan ◽  
Christopher McGee ◽  
Rebecca Webb ◽  
Mark Joy ◽  
Rachel Byford ◽  
...  

BACKGROUND Living in a conurbation, urban, or rural environment is an important determinant of health. For example, conurbation and rural living is associated with increased respiratory and allergic conditions, whereas a farm or rural upbringing has been shown to be a protective factor against this. OBJECTIVE The objective of the study was to assess differences in general practice presentations of allergic and infectious disease in those exposed to conurbation or urban living compared with rural environments. METHODS The population was a nationally representative sample of 175 English general practices covering a population of over 1.6 million patients registered with sentinel network general practices. General practice presentation rates per 100,000 population were reported for allergic rhinitis, asthma, and infectious conditions grouped into upper and lower respiratory tract infections, urinary tract infection, and acute gastroenteritis by the UK Office for National Statistics urban-rural category. We used multivariate logistic regression adjusting for age, sex, ethnicity, deprivation, comorbidities, and smoking status, reporting odds ratios (ORs) with 95% CIs. RESULTS For allergic rhinitis, the OR was 1.13 (95% CI 1.04-1.23; P=.003) for urban and 1.29 (95% CI 1.19-1.41; P<.001) for conurbation compared with rural dwellers. Conurbation living was associated with a lower OR for both asthma (OR 0.70, 95% CI 0.67-0.73; P<.001) and lower respiratory tract infections (OR 0.94, 95% CI 0.90-0.98; P=.005). Compared with rural dwellers, the OR for upper respiratory tract infection was greater in urban (OR 1.06, 95% CI 1.03-1.08; P<.001) but no different in conurbation dwellers (OR 1.00, 95% CI 0.97-1.03; P=.93). Acute gastroenteritis followed the same pattern: the OR was 1.13 (95% CI 1.01-1.25; P=.03) for urban dwellers and 1.04 (95% CI 0.93-1.17; P=.46) for conurbation dwellers. The OR for urinary tract infection was lower for urban dwellers (OR 0.94, 95% CI 0.89-0.99; P=.02) but higher in conurbation dwellers (OR 1.06, 95% CI 1.00-1.13; P=.04). CONCLUSIONS Those living in conurbations or urban areas were more likely to consult a general practice for allergic rhinitis and upper respiratory tract infection. Both conurbation and rural living were associated with an increased risk of urinary tract infection. Living in rural areas was associated with an increased risk of asthma and lower respiratory tract infections. The data suggest that living environment may affect rates of consultations for certain conditions. Longitudinal analyses of these data would be useful in providing insights into important determinants.


Sign in / Sign up

Export Citation Format

Share Document